nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—CYP2C9—urine—polycystic ovary syndrome	0.0161	0.0722	CbGeAlD
Bosentan—EDNRB—adrenal cortex—polycystic ovary syndrome	0.0156	0.0699	CbGeAlD
Bosentan—EDNRB—endometrium—polycystic ovary syndrome	0.0139	0.0624	CbGeAlD
Bosentan—EDNRA—adrenal cortex—polycystic ovary syndrome	0.0129	0.0578	CbGeAlD
Bosentan—EDNRB—uterus—polycystic ovary syndrome	0.0129	0.0575	CbGeAlD
Bosentan—Loose stools—Metformin—polycystic ovary syndrome	0.0127	0.0503	CcSEcCtD
Bosentan—EDNRB—pituitary gland—polycystic ovary syndrome	0.0126	0.0565	CbGeAlD
Bosentan—EDNRB—adipose tissue—polycystic ovary syndrome	0.0126	0.0563	CbGeAlD
Bosentan—CYP3A4—urine—polycystic ovary syndrome	0.0123	0.055	CbGeAlD
Bosentan—Toothache—Metformin—polycystic ovary syndrome	0.0116	0.0458	CcSEcCtD
Bosentan—EDNRA—endometrium—polycystic ovary syndrome	0.0115	0.0516	CbGeAlD
Bosentan—EDNRB—adrenal gland—polycystic ovary syndrome	0.0113	0.0505	CbGeAlD
Bosentan—EDNRA—uterus—polycystic ovary syndrome	0.0106	0.0476	CbGeAlD
Bosentan—EDNRB—female gonad—polycystic ovary syndrome	0.0105	0.0471	CbGeAlD
Bosentan—EDNRB—vagina—polycystic ovary syndrome	0.0105	0.0468	CbGeAlD
Bosentan—EDNRA—pituitary gland—polycystic ovary syndrome	0.0104	0.0467	CbGeAlD
Bosentan—EDNRA—adipose tissue—polycystic ovary syndrome	0.0104	0.0465	CbGeAlD
Bosentan—EDNRA—adrenal gland—polycystic ovary syndrome	0.00932	0.0417	CbGeAlD
Bosentan—EDNRA—female gonad—polycystic ovary syndrome	0.00869	0.0389	CbGeAlD
Bosentan—EDNRA—vagina—polycystic ovary syndrome	0.00864	0.0387	CbGeAlD
Bosentan—Contusion—Metformin—polycystic ovary syndrome	0.00806	0.0319	CcSEcCtD
Bosentan—ABCB11—endocrine gland—polycystic ovary syndrome	0.0079	0.0353	CbGeAlD
Bosentan—Nasal congestion—Metformin—polycystic ovary syndrome	0.0056	0.0222	CcSEcCtD
Bosentan—Renal impairment—Metformin—polycystic ovary syndrome	0.00536	0.0212	CcSEcCtD
Bosentan—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00523	0.0207	CcSEcCtD
Bosentan—Lethargy—Metformin—polycystic ovary syndrome	0.00521	0.0206	CcSEcCtD
Bosentan—Pain in extremity—Metformin—polycystic ovary syndrome	0.0051	0.0202	CcSEcCtD
Bosentan—Dehydration—Metformin—polycystic ovary syndrome	0.00475	0.0188	CcSEcCtD
Bosentan—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00471	0.0187	CcSEcCtD
Bosentan—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00466	0.0185	CcSEcCtD
Bosentan—Cramp muscle—Metformin—polycystic ovary syndrome	0.0046	0.0182	CcSEcCtD
Bosentan—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00456	0.0181	CcSEcCtD
Bosentan—Abdominal distension—Metformin—polycystic ovary syndrome	0.00444	0.0176	CcSEcCtD
Bosentan—Influenza—Metformin—polycystic ovary syndrome	0.00441	0.0175	CcSEcCtD
Bosentan—Angina pectoris—Metformin—polycystic ovary syndrome	0.0043	0.017	CcSEcCtD
Bosentan—Sweating increased—Metformin—polycystic ovary syndrome	0.0043	0.017	CcSEcCtD
Bosentan—Neutropenia—Metformin—polycystic ovary syndrome	0.00412	0.0163	CcSEcCtD
Bosentan—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.0041	0.0162	CcSEcCtD
Bosentan—Infestation NOS—Metformin—polycystic ovary syndrome	0.00393	0.0156	CcSEcCtD
Bosentan—Infestation—Metformin—polycystic ovary syndrome	0.00393	0.0156	CcSEcCtD
Bosentan—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00372	0.0147	CcSEcCtD
Bosentan—Bradycardia—Metformin—polycystic ovary syndrome	0.00359	0.0142	CcSEcCtD
Bosentan—Hepatitis—Metformin—polycystic ovary syndrome	0.00353	0.014	CcSEcCtD
Bosentan—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00351	0.0139	CcSEcCtD
Bosentan—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00348	0.0138	CcSEcCtD
Bosentan—Eye disorder—Metformin—polycystic ovary syndrome	0.0033	0.0131	CcSEcCtD
Bosentan—Flushing—Metformin—polycystic ovary syndrome	0.00328	0.013	CcSEcCtD
Bosentan—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00328	0.013	CcSEcCtD
Bosentan—Angiopathy—Metformin—polycystic ovary syndrome	0.0032	0.0127	CcSEcCtD
Bosentan—Immune system disorder—Metformin—polycystic ovary syndrome	0.00319	0.0126	CcSEcCtD
Bosentan—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00318	0.0126	CcSEcCtD
Bosentan—Chills—Metformin—polycystic ovary syndrome	0.00317	0.0125	CcSEcCtD
Bosentan—Malnutrition—Metformin—polycystic ovary syndrome	0.00307	0.0122	CcSEcCtD
Bosentan—Erythema—Metformin—polycystic ovary syndrome	0.00307	0.0122	CcSEcCtD
Bosentan—Flatulence—Metformin—polycystic ovary syndrome	0.00303	0.012	CcSEcCtD
Bosentan—Muscle spasms—Metformin—polycystic ovary syndrome	0.00295	0.0117	CcSEcCtD
Bosentan—Vision blurred—Metformin—polycystic ovary syndrome	0.0029	0.0115	CcSEcCtD
Bosentan—Tremor—Metformin—polycystic ovary syndrome	0.00288	0.0114	CcSEcCtD
Bosentan—Syncope—Metformin—polycystic ovary syndrome	0.00276	0.0109	CcSEcCtD
Bosentan—Palpitations—Metformin—polycystic ovary syndrome	0.00272	0.0108	CcSEcCtD
Bosentan—Loss of consciousness—Metformin—polycystic ovary syndrome	0.0027	0.0107	CcSEcCtD
Bosentan—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00267	0.012	CbGeAlD
Bosentan—Chest pain—Metformin—polycystic ovary syndrome	0.00262	0.0104	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.0026	0.0103	CcSEcCtD
Bosentan—Discomfort—Metformin—polycystic ovary syndrome	0.00259	0.0102	CcSEcCtD
Bosentan—Oedema—Metformin—polycystic ovary syndrome	0.00251	0.00993	CcSEcCtD
Bosentan—Infection—Metformin—polycystic ovary syndrome	0.00249	0.00987	CcSEcCtD
Bosentan—Shock—Metformin—polycystic ovary syndrome	0.00247	0.00977	CcSEcCtD
Bosentan—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00246	0.00974	CcSEcCtD
Bosentan—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00246	0.00972	CcSEcCtD
Bosentan—Skin disorder—Metformin—polycystic ovary syndrome	0.00244	0.00965	CcSEcCtD
Bosentan—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00242	0.0096	CcSEcCtD
Bosentan—Anorexia—Metformin—polycystic ovary syndrome	0.00239	0.00947	CcSEcCtD
Bosentan—Hypotension—Metformin—polycystic ovary syndrome	0.00234	0.00928	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00229	0.00905	CcSEcCtD
Bosentan—Paraesthesia—Metformin—polycystic ovary syndrome	0.00225	0.00892	CcSEcCtD
Bosentan—Dyspnoea—Metformin—polycystic ovary syndrome	0.00224	0.00885	CcSEcCtD
Bosentan—Somnolence—Metformin—polycystic ovary syndrome	0.00223	0.00883	CcSEcCtD
Bosentan—Dyspepsia—Metformin—polycystic ovary syndrome	0.00221	0.00874	CcSEcCtD
Bosentan—Decreased appetite—Metformin—polycystic ovary syndrome	0.00218	0.00863	CcSEcCtD
Bosentan—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00217	0.00857	CcSEcCtD
Bosentan—Fatigue—Metformin—polycystic ovary syndrome	0.00216	0.00856	CcSEcCtD
Bosentan—Constipation—Metformin—polycystic ovary syndrome	0.00214	0.00849	CcSEcCtD
Bosentan—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00205	0.00812	CcSEcCtD
Bosentan—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00204	0.00913	CbGeAlD
Bosentan—Urticaria—Metformin—polycystic ovary syndrome	0.00199	0.00789	CcSEcCtD
Bosentan—Abdominal pain—Metformin—polycystic ovary syndrome	0.00198	0.00785	CcSEcCtD
Bosentan—Asthenia—Metformin—polycystic ovary syndrome	0.0018	0.00712	CcSEcCtD
Bosentan—Pruritus—Metformin—polycystic ovary syndrome	0.00177	0.00703	CcSEcCtD
Bosentan—Diarrhoea—Metformin—polycystic ovary syndrome	0.00172	0.00679	CcSEcCtD
Bosentan—Dizziness—Metformin—polycystic ovary syndrome	0.00166	0.00657	CcSEcCtD
Bosentan—Vomiting—Metformin—polycystic ovary syndrome	0.00159	0.00631	CcSEcCtD
Bosentan—Rash—Metformin—polycystic ovary syndrome	0.00158	0.00626	CcSEcCtD
Bosentan—Dermatitis—Metformin—polycystic ovary syndrome	0.00158	0.00626	CcSEcCtD
Bosentan—Headache—Metformin—polycystic ovary syndrome	0.00157	0.00622	CcSEcCtD
Bosentan—Nausea—Metformin—polycystic ovary syndrome	0.00149	0.0059	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000363	0.000693	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000359	0.000686	CbGpPWpGaD
Bosentan—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000356	0.00068	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000355	0.000677	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000352	0.000671	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000351	0.000669	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—AKR1C2—polycystic ovary syndrome	0.000349	0.000665	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—TEAD2—polycystic ovary syndrome	0.000349	0.000665	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000348	0.000665	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—SCT—polycystic ovary syndrome	0.000348	0.000664	CbGpPWpGaD
Bosentan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000348	0.000663	CbGpPWpGaD
Bosentan—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000347	0.000661	CbGpPWpGaD
Bosentan—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000344	0.000657	CbGpPWpGaD
Bosentan—CYP2C9—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000344	0.000656	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000344	0.000656	CbGpPWpGaD
Bosentan—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000343	0.000655	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000335	0.00064	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000335	0.00064	CbGpPWpGaD
Bosentan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000334	0.000637	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000332	0.000634	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000331	0.000631	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.00033	0.00063	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000327	0.000624	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000326	0.000623	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000323	0.000617	CbGpPWpGaD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000322	0.000615	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000319	0.000608	CbGpPWpGaD
Bosentan—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000317	0.000605	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000309	0.000589	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000305	0.000583	CbGpPWpGaD
Bosentan—CYP2C9—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000304	0.000581	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000302	0.000576	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000299	0.000571	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000298	0.000568	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000297	0.000567	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PNPLA2—polycystic ovary syndrome	0.000292	0.000557	CbGpPWpGaD
Bosentan—CYP2C9—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000287	0.000548	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000287	0.000548	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000287	0.000547	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—INSR—polycystic ovary syndrome	0.000285	0.000544	CbGpPWpGaD
Bosentan—CYP2C9—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000283	0.00054	CbGpPWpGaD
Bosentan—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000282	0.000538	CbGpPWpGaD
Bosentan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00028	0.000535	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000279	0.000533	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—SRD5A1—polycystic ovary syndrome	0.000277	0.000528	CbGpPWpGaD
Bosentan—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000277	0.000528	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—FST—polycystic ovary syndrome	0.000272	0.00052	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000271	0.000517	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000271	0.000516	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000269	0.000513	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000266	0.000508	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—LHB—polycystic ovary syndrome	0.000266	0.000507	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—STAR—polycystic ovary syndrome	0.000264	0.000504	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PGR—polycystic ovary syndrome	0.000264	0.000503	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000261	0.000499	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000261	0.000499	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000261	0.000498	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.00026	0.000496	CbGpPWpGaD
Bosentan—CYP2C9—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000257	0.00049	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000252	0.00048	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000251	0.000479	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SCT—polycystic ovary syndrome	0.000249	0.000475	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000246	0.00047	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000246	0.000469	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000245	0.000468	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000245	0.000468	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000238	0.000453	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000236	0.000451	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—HMMR—polycystic ovary syndrome	0.000235	0.000449	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000234	0.000446	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000233	0.000446	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000232	0.000442	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000231	0.00044	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00023	0.000438	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000228	0.000435	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000228	0.000435	CbGpPWpGaD
Bosentan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000227	0.000434	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000227	0.000433	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000227	0.000433	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000227	0.000432	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—HSD3B1—polycystic ovary syndrome	0.000225	0.000429	CbGpPWpGaD
Bosentan—CYP2C9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000224	0.000427	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000222	0.000424	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000219	0.000418	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000216	0.000412	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000216	0.000412	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000214	0.000409	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PRL—polycystic ovary syndrome	0.000214	0.000408	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000213	0.000407	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.00021	0.000402	CbGpPWpGaD
Bosentan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000209	0.000399	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000208	0.000396	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000206	0.000393	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—LHB—polycystic ovary syndrome	0.000205	0.000391	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—INSR—polycystic ovary syndrome	0.000204	0.000389	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000203	0.000388	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000203	0.000387	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000201	0.000383	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—HSD3B2—polycystic ovary syndrome	0.0002	0.000382	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000198	0.000378	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—AKR1C1—polycystic ovary syndrome	0.000194	0.00037	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000194	0.00037	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000191	0.000364	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00019	0.000362	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000189	0.000361	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PGR—polycystic ovary syndrome	0.000189	0.00036	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000188	0.000359	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000187	0.000356	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000183	0.000349	CbGpPWpGaD
Bosentan—CYP2C9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.00018	0.000344	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000179	0.000342	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—SULT2A1—polycystic ovary syndrome	0.000178	0.000341	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000176	0.000336	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000175	0.000335	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000175	0.000335	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—RRM2—polycystic ovary syndrome	0.000173	0.00033	CbGpPWpGaD
Bosentan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000169	0.000323	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000169	0.000323	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000168	0.000321	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000167	0.000319	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—YAP1—polycystic ovary syndrome	0.000167	0.000318	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000163	0.000312	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000162	0.00031	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NMNAT3—polycystic ovary syndrome	0.000161	0.000307	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—NAMPT—polycystic ovary syndrome	0.00016	0.000305	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000159	0.000304	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CYP11A1—polycystic ovary syndrome	0.000158	0.000302	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000157	0.000299	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000154	0.000295	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000154	0.000293	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000154	0.000293	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PRL—polycystic ovary syndrome	0.000153	0.000292	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000151	0.000288	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00015	0.000286	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00015	0.000286	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—AKR1C3—polycystic ovary syndrome	0.000149	0.000285	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000148	0.000282	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000148	0.000282	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—LEP—polycystic ovary syndrome	0.000147	0.000281	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	0.000147	0.000281	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	0.000147	0.000281	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CYP17A1—polycystic ovary syndrome	0.000147	0.00028	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000145	0.000277	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000145	0.000277	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000137	0.000261	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	0.000136	0.00026	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000135	0.000257	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000134	0.000255	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000132	0.000251	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000128	0.000245	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—TH—polycystic ovary syndrome	0.000127	0.000243	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—POMC—polycystic ovary syndrome	0.000127	0.000242	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—INS—polycystic ovary syndrome	0.000126	0.00024	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000126	0.00024	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000125	0.000238	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—SLC2A4—polycystic ovary syndrome	0.000124	0.000236	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000122	0.000233	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000122	0.000232	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000121	0.00023	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000119	0.000227	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000118	0.000226	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.000116	0.000222	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000116	0.000222	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CYP19A1—polycystic ovary syndrome	0.000116	0.000222	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000116	0.000221	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000112	0.000214	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.00011	0.00021	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000108	0.000206	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000106	0.000203	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—LEP—polycystic ovary syndrome	0.000106	0.000201	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GNAS—polycystic ovary syndrome	0.000104	0.000198	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—NCOR1—polycystic ovary syndrome	9.89e-05	0.000189	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	9.75e-05	0.000186	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	9.71e-05	0.000185	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	9.71e-05	0.000185	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IRS1—polycystic ovary syndrome	9.42e-05	0.00018	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CYP1A1—polycystic ovary syndrome	9.37e-05	0.000179	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—IL6—polycystic ovary syndrome	9.32e-05	0.000178	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	9.24e-05	0.000176	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—POMC—polycystic ovary syndrome	9.07e-05	0.000173	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	9.03e-05	0.000172	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—INS—polycystic ovary syndrome	9.02e-05	0.000172	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	9e-05	0.000172	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	8.82e-05	0.000168	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—MTHFR—polycystic ovary syndrome	8.74e-05	0.000167	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IGF1—polycystic ovary syndrome	8.72e-05	0.000166	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	8.72e-05	0.000166	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—AKT2—polycystic ovary syndrome	8.72e-05	0.000166	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.28e-05	0.000158	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.96e-05	0.000152	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	7.86e-05	0.00015	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	7.67e-05	0.000146	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	7.67e-05	0.000146	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	7.5e-05	0.000143	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	7.41e-05	0.000141	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PPARG—polycystic ovary syndrome	7.09e-05	0.000135	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	7.03e-05	0.000134	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—POMC—polycystic ovary syndrome	6.99e-05	0.000133	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—INS—polycystic ovary syndrome	6.95e-05	0.000133	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	6.84e-05	0.00013	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	6.68e-05	0.000128	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL6—polycystic ovary syndrome	6.67e-05	0.000127	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	6.47e-05	0.000124	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	6.43e-05	0.000123	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	6.1e-05	0.000116	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	5.96e-05	0.000114	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	5.82e-05	0.000111	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	5.77e-05	0.00011	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.7e-05	0.000109	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	5.56e-05	0.000106	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL6—polycystic ovary syndrome	5.51e-05	0.000105	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	5.34e-05	0.000102	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.31e-05	0.000101	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	5.28e-05	0.000101	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.24e-05	0.0001	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	5.18e-05	9.89e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	4.98e-05	9.51e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	4.95e-05	9.44e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	4.91e-05	9.36e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	4.51e-05	8.61e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	4.41e-05	8.41e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	4.27e-05	8.15e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—TH—polycystic ovary syndrome	4.24e-05	8.1e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	4.13e-05	7.88e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL6—polycystic ovary syndrome	3.94e-05	7.52e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	3.93e-05	7.5e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	3.88e-05	7.41e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	3.8e-05	7.26e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	3.67e-05	7e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	3.52e-05	6.72e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	3.48e-05	6.64e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	3.47e-05	6.61e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	3.3e-05	6.3e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	3.29e-05	6.27e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	3.24e-05	6.17e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	3.13e-05	5.97e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	2.92e-05	5.57e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.8e-05	5.34e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.72e-05	5.2e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.56e-05	4.89e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	2.37e-05	4.51e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	2.33e-05	4.45e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—INS—polycystic ovary syndrome	2.32e-05	4.43e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.29e-05	4.36e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	2.18e-05	4.15e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.06e-05	3.94e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.92e-05	3.67e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.56e-05	2.98e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.54e-05	2.94e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.53e-05	2.92e-05	CbGpPWpGaD
